PE20051052A1 - NITROOXY DERIVATIVES OF PROSTAGLANDINS - Google Patents
NITROOXY DERIVATIVES OF PROSTAGLANDINSInfo
- Publication number
- PE20051052A1 PE20051052A1 PE2005000037A PE2005000037A PE20051052A1 PE 20051052 A1 PE20051052 A1 PE 20051052A1 PE 2005000037 A PE2005000037 A PE 2005000037A PE 2005000037 A PE2005000037 A PE 2005000037A PE 20051052 A1 PE20051052 A1 PE 20051052A1
- Authority
- PE
- Peru
- Prior art keywords
- ono2
- phenylpentil
- heptenoico
- cyclopentil
- hydroxy
- Prior art date
Links
- -1 NITROOXY Chemical class 0.000 title abstract 6
- 150000003180 prostaglandins Chemical class 0.000 title abstract 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 title abstract 2
- 229910004679 ONO2 Inorganic materials 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 abstract 1
- 206010018307 Glaucoma and ocular hypertension Diseases 0.000 abstract 1
- 108050004689 Inhibitor of carbonic anhydrases Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000048 adrenergic agonist Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960004605 timolol Drugs 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- MKPLKVHSHYCHOC-AHTXBMBWSA-N travoprost Chemical compound CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(C(F)(F)F)=C1 MKPLKVHSHYCHOC-AHTXBMBWSA-N 0.000 abstract 1
- 229960002368 travoprost Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Abstract
SE REFIERE A COMPUESTOS DERIVADOS NITROOXI DE PROSTAGLANDINAS DE FORMULA: R-X-Y-ONO2; EN DONDE R ES EL RESIDUO DE PROSTAGLANDINA DE FORMULA (II), EN DONDE L ES -(CH2)5-CH3, METILFENIL, 3-TRIFLUOROMETILFENOXI O 3-CLOROFENOXI, SIENDO PREFERIDOS PARA R: TRAVOPROST, UNOPROSTONA Y CLOPROSTENOL; X ES -O-, -S- O -NH-; Y ES UN RADICAL BIVALENTE, COMO ALQUILENO(C1-C20) LINEAL O RAMIFICADO, OPCIONALMENTE SUSTITUIDO CON HALOGENO, HIDROXI, -ONO2- O -OC(O)(ALQUIL(C1-C10))-ONO2 O -O(ALQUIL(C1-C10)-ONO2; O CICLOALQUILENO(C5-C7) OPCIONALMENTE SUSTITUIDO, -(CH2)n-(C6H4)-(CH2)n1-, -[C6H3(OR2)n2]-X1-(CH2)n1-, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 4(NITROOXI)BUTIL ESTER DEL ACIDO [1R-[1a(Z),2a(R*),3a,5a]]-7-[3,5-DIHIDROXI-2(3-HIDROXI-5-FENILPENTIL)CICLOPENTIL]-5-HEPTENOICO, (2-METOXI-4-[2-PROPENOILOXI(4-NITROOXIBUTIL)1]FENIL ESTER DEL ACIDO [1R-[1a(Z),2b(R*),3a,5a]]-7-[3,5-DIHIDROXI-2(3-HIDROXI-5-FENILPENTIL)CICLOPENTIL]-5-HEPTENOICO, 3(NITROOXIMETIL)FENIL ESTER DEL ACIDO [1R-[1a(Z),2b(R*),3a,5a]]-7-[3,5-DIHIDROXI-2(3-HIDROXI-5-FENILPENTIL)CICLOPENTIL]-5-HEPTENOICO, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCESO DE ELABORACION Y UNA COMPOSICION FARMACEUTICA DE ADMINISTRACION TOPICA COMO SOLUCION, SUSPENCION O EMULSION DE USO OFTALMICO, ADEMAS PUEDE ESTAR EN COMBINACION CON OTRO AGENTE ACTIVO COMO UN ß-BLOQUEANTE ESPECILAMENTE TIMOLOL, INHIBIDOR DE LA ANHIDRASA CARBONICA, O AGONISTA ADRENERGICO. ESTOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DE GLAUCOMA Y DE LA HIPERTENSION OCULARREFERS TO NITROOXY DERIVED COMPOUNDS FROM PROSTAGLANDINS OF THE FORMULA: R-X-Y-ONO2; WHERE R IS THE RESIDUE OF PROSTAGLANDIN OF FORMULA (II), WHERE L IS - (CH2) 5-CH3, METHYLPHENYL, 3-TRIFLUOROMETHYLPHENOXY OR 3-CHLOROPHENOXY, BEING PREFERRED FOR R: TRAVOPROST;, UNOPROSTTONA; X IS -O-, -S- O -NH-; AND IT IS A BIVALENT RADICAL, LIKE LINEAR OR BRANCHED ALKYLENE (C1-C20), OPTIONALLY SUBSTITUTED WITH HALOGEN, HYDROXY, -ONO2- OR -OC (O) (ALKYL (C1-C10)) - ONO2 OR -O (ALKYL (C1 -C10) -ONO2; OR CYCLOALKYLENE (C5-C7) OPTIONALLY SUBSTITUTED, - (CH2) n- (C6H4) - (CH2) n1-, - [C6H3 (OR2) n2] -X1- (CH2) n1-, BETWEEN OTHERS ARE PREFERRED COMPOUNDS: 4 (NITROOXY) BUTYL ESTER OF ACID [1R- [1a (Z), 2a (R *), 3a, 5a]] - 7- [3,5-DIHIDROXI-2 (3-HYDROXI- 5-PHENYLPENTIL) CYCLOPENTIL] -5-HEPTENOICO, (2-METOXI-4- [2-PROPENOYLOXY (4-NITROOXIBUTTIL) 1] ACID [1R- [1a (Z), 2b (R *), 3a, 5a]] - 7- [3,5-DIHYDROXY-2 (3-HYDROXY-5-PHENYLPENTIL) CYCLOPENTIL] -5-HEPTENOICO, 3 (NITROOXIMETIL) ACIDO [1R- [1a (Z), 2b (R *), 3a, 5a]] - 7- [3,5-DIHYDROXY-2 (3-HYDROXY-5-PHENYLPENTIL) CYCLOPENTIL] -5-HEPTENOICO, AMONG OTHERS. ALSO REFERS TO A PREPARATION PROCESS AND A PHARMACEUTICAL COMPOSITION OF TOPICAL ADMINISTRATION AS A SOLUTION, SUSPENTION OR EMULSION FOR OPHTHALMIC USE, IN ADDITION IT MAY BE IN COMBINATION WITH ANOTHER ACTIVE AGENT SUCH AS A ß-BLOCKANT ESPECIALLY TIMOLOL, INHIBITOR OF CARBONIC ANHYDRASE, OR ADRENERGIC AGONIST. THESE COMPOUNDS ARE USEFUL FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04100001 | 2004-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20051052A1 true PE20051052A1 (en) | 2005-12-17 |
Family
ID=34778199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000037A PE20051052A1 (en) | 2004-01-05 | 2005-01-04 | NITROOXY DERIVATIVES OF PROSTAGLANDINS |
Country Status (40)
| Country | Link |
|---|---|
| US (5) | US7273946B2 (en) |
| EP (3) | EP1704141B1 (en) |
| JP (1) | JP3984283B2 (en) |
| KR (2) | KR100854838B1 (en) |
| CN (1) | CN100469765C (en) |
| AP (1) | AP2006003638A0 (en) |
| AR (2) | AR047081A1 (en) |
| AU (1) | AU2004313688B2 (en) |
| BR (1) | BRPI0418245B8 (en) |
| CA (1) | CA2551409C (en) |
| CR (2) | CR8498A (en) |
| CY (1) | CY1117417T1 (en) |
| DK (1) | DK1704141T3 (en) |
| EA (1) | EA010595B1 (en) |
| EC (1) | ECSP066684A (en) |
| ES (2) | ES2566800T3 (en) |
| GE (1) | GEP20094780B (en) |
| GT (1) | GT200500293A (en) |
| HK (1) | HK1096084A1 (en) |
| HR (1) | HRP20160500T1 (en) |
| HU (1) | HUE027357T2 (en) |
| IL (1) | IL176416A (en) |
| MA (1) | MA28284A1 (en) |
| ME (1) | ME02433B (en) |
| MX (1) | MXPA06007678A (en) |
| MY (1) | MY147181A (en) |
| NO (2) | NO337217B1 (en) |
| NZ (1) | NZ548271A (en) |
| OA (1) | OA13356A (en) |
| PA (1) | PA8620901A1 (en) |
| PE (1) | PE20051052A1 (en) |
| PL (1) | PL1704141T3 (en) |
| RS (1) | RS54717B1 (en) |
| SI (1) | SI1704141T1 (en) |
| TN (1) | TNSN06210A1 (en) |
| TW (1) | TWI337994B (en) |
| UA (1) | UA84726C2 (en) |
| UY (1) | UY28709A1 (en) |
| WO (1) | WO2005068421A1 (en) |
| ZA (1) | ZA200605354B (en) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA13356A (en) | 2004-01-05 | 2007-04-13 | Nicox Sa | Prostaglandin nitrooxyderivatives. |
| JP2009501150A (en) * | 2005-06-29 | 2009-01-15 | ファイザー・インク | Prostaglandin derivatives |
| EP1917239A1 (en) * | 2005-06-29 | 2008-05-07 | Pfizer, Inc. | Fluoroprostaglandins nitroderivatives |
| WO2007126609A1 (en) * | 2006-03-29 | 2007-11-08 | Nitromed, Inc. | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
| US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
| US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
| DE102006052755A1 (en) * | 2006-11-08 | 2008-05-15 | N-Zyme Biotec Gmbh | New peptide derivatives and peptidomimetics are transglutaminase inhibitors useful for the treatment or prophylaxis of e.g. celiac disease, fibrosis, thrombosis, neurodegenerative disorders, Huntington's chorea and Parkinson disease |
| US20100063035A1 (en) | 2006-12-15 | 2010-03-11 | Nicox S.A. | Carbonic anhydrase inhibitors derivatives |
| WO2008071421A1 (en) * | 2006-12-15 | 2008-06-19 | Nicox S.A. | Nitrate esters of carbonic anhydrase inhibitors |
| JP2010529101A (en) | 2007-06-04 | 2010-08-26 | テックフィールズ インコーポレイテッド | NSAIA prodrug with very fast skin and membrane permeation rate and novel pharmaceutical use thereof |
| WO2009035565A1 (en) * | 2007-09-07 | 2009-03-19 | Qlt Plug Delivery, Inc | Prostaglandin analogues for implant devices and methods |
| US7553874B2 (en) * | 2007-10-31 | 2009-06-30 | Meta Cosmetics, Llc | Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| AR076731A1 (en) * | 2008-05-09 | 2011-07-06 | Pfizer | GIVING PRESSURES OF NITRIC OXIDE, USE OF THE SAME AND PHARMACEUTICAL COMPOSITIONS |
| US7807716B2 (en) * | 2008-09-24 | 2010-10-05 | Oral Delivery Technology Ltd. | Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use |
| KR101946297B1 (en) | 2008-12-04 | 2019-02-11 | 충시 위 | High Penetration Compositions and Their Applications |
| WO2010077101A2 (en) | 2008-12-30 | 2010-07-08 | 조선대학교산학협력단 | Novel thiazolidinedione derivative and use thereof |
| WO2011032936A1 (en) * | 2009-09-15 | 2011-03-24 | Dsm Ip Assets B.V. | Nitrooxyesters, their preparation and use |
| CN101885684B (en) * | 2010-07-01 | 2013-10-30 | 南京中医药大学 | Aromatic acid pro-drug with nitrogen monoxide donor, and preparation method and application thereof |
| DK3290024T3 (en) | 2011-08-29 | 2019-06-03 | Mati Therapeutics Inc | CONTINUING SUBMISSION OF ACTIVE RESOURCES FOR TREATMENT OF GLAUCUM AND OCULAR HYPERTENSION |
| HU231203B1 (en) * | 2011-12-21 | 2021-10-28 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Novel process for the preparation of travoprost |
| EP2844224B1 (en) | 2012-05-03 | 2018-04-11 | Mati Therapeutics Inc. | Drug delivery system for treating open angle glaucoma and ocular hypertension |
| JP6405312B2 (en) * | 2012-10-23 | 2018-10-17 | ニコックス サイエンス アイルランド | Quinone-based nitric oxide donor compounds for ophthalmology |
| WO2014170264A1 (en) * | 2013-04-18 | 2014-10-23 | Nicox Science Ireland | Quinone based nitric oxide donating compounds for ophthalmic use |
| CA2935957C (en) | 2014-01-10 | 2023-01-03 | Manistee Partners Llc | Treatment of migraines using topical administration of prostaglandin f2alpha analogs |
| US9604949B2 (en) * | 2014-10-15 | 2017-03-28 | Novartis Ag | Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension |
| US10280138B2 (en) | 2015-03-31 | 2019-05-07 | Nicox S.A. | Nitric oxide donating derivatives of fluprostenol |
| WO2016156104A1 (en) | 2015-03-31 | 2016-10-06 | Nicox S.A. | Nitric oxide donating derivatives of latanoprost free acid |
| EP3088388A1 (en) | 2015-04-30 | 2016-11-02 | NicOx S.A. | Nitric oxide donating derivatives of prostaglandins |
| MX2018003462A (en) | 2015-09-22 | 2018-09-06 | Graybug Vision Inc | Compounds and compositions for the treatment of ocular disorders. |
| HU231175B1 (en) * | 2015-12-04 | 2021-06-28 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Production of latanoprostene bunod by gravity column chromatography, in optional, previously definied quality |
| JP7055802B2 (en) * | 2016-11-08 | 2022-04-18 | ボシュ・アンド・ロム・インコーポレイテッド | Nitric oxide-releasing prostaglandin derivative for treating normal-tension glaucoma |
| KR102069205B1 (en) * | 2017-08-09 | 2020-01-22 | 연성정밀화학(주) | Process for Preparing Latanoprostene bunod and Intermediate Therefor |
| RU2718744C2 (en) * | 2018-05-17 | 2020-04-14 | Общество с ограниченной ответственностью "Гурус БиоФарм" | Prostaglandin f2alpha derivatives for reducing intraocular pressure |
| CN109988089B (en) * | 2018-05-29 | 2022-04-26 | 上海凡秦医药科技有限公司 | Prostaglandin compound, preparation method and application thereof |
| CN108892624B (en) * | 2018-06-20 | 2020-12-15 | 重庆威鹏药业有限公司 | Sacubitril nitroxide derivative and preparation method and application thereof |
| US11332433B2 (en) * | 2020-07-24 | 2022-05-17 | Chirogate International Inc. | Process for the preparation of latanoprostene bunod and intermediate thereof and compositions comprising the same |
| CN113943266A (en) * | 2021-11-18 | 2022-01-18 | 广州楷石医药有限公司 | Nitric oxide donor type beraprost derivative and pharmaceutical composition and application thereof |
| CN116444377A (en) * | 2022-01-07 | 2023-07-18 | 广州楷石医药有限公司 | Nitric oxide donor type treprostinil derivative, and pharmaceutical composition and application thereof |
| CA3195291A1 (en) * | 2022-04-13 | 2023-10-13 | Caravel Therapeutics, Inc. | Preservative-free ophthalmic pharmaceutical emulsion and its application |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3922293A (en) | 1971-12-30 | 1975-11-25 | Upjohn Co | Prostaglandin F-type 9-monoacylates |
| US4952581A (en) | 1987-04-03 | 1990-08-28 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
| DE68913000T3 (en) | 1988-09-06 | 2004-10-21 | Pharmacia Ab | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension. |
| EP0664707B1 (en) | 1992-10-13 | 1997-06-04 | Alcon Laboratories, Inc. | Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma |
| US5328933A (en) * | 1992-10-28 | 1994-07-12 | Allergan, Inc. | Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues |
| US5625083A (en) | 1995-06-02 | 1997-04-29 | Bezuglov; Vladimir V. | Dinitroglycerol esters of unsaturated fatty acids and prostaglandins |
| IT1295694B1 (en) | 1996-11-14 | 1999-05-27 | Nicox Sa | NITROXIS DERIVATIVES FOR THE PREPARATION OF MEDICATIONS WITH ANTI-THROMBINIC ACTIVITY |
| IT1292377B1 (en) * | 1997-06-19 | 1999-02-08 | Nicox Sa | PROSTAGLANDINE PHARMACEUTICAL COMPOSITIONS |
| US6417228B1 (en) | 1998-11-02 | 2002-07-09 | Alcon Manufacturing, Ltd.. | 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension |
| AU3713600A (en) | 1999-03-01 | 2000-09-21 | Nitromed, Inc. | Nitrosated and nitrosylated prostaglandins, compositions and metods of use |
| US20030018079A1 (en) | 2000-11-13 | 2003-01-23 | Richardson Helene | Treatment |
| KR100875908B1 (en) * | 2001-04-19 | 2008-12-26 | 테이카 세이야쿠 가부시키가이샤 | Drugs and Pharmaceutical Kits |
| OA13356A (en) | 2004-01-05 | 2007-04-13 | Nicox Sa | Prostaglandin nitrooxyderivatives. |
-
2004
- 2004-12-27 OA OA1200600221A patent/OA13356A/en unknown
- 2004-12-27 GE GEAP20049494A patent/GEP20094780B/en unknown
- 2004-12-27 ES ES04804405.1T patent/ES2566800T3/en active Active
- 2004-12-27 JP JP2006546105A patent/JP3984283B2/en active Active
- 2004-12-27 EP EP04804405.1A patent/EP1704141B1/en active Active
- 2004-12-27 RS RS20160251A patent/RS54717B1/en unknown
- 2004-12-27 AU AU2004313688A patent/AU2004313688B2/en active Active
- 2004-12-27 WO PCT/EP2004/014820 patent/WO2005068421A1/en active Application Filing
- 2004-12-27 BR BRPI0418245A patent/BRPI0418245B8/en active IP Right Grant
- 2004-12-27 EA EA200601099A patent/EA010595B1/en not_active IP Right Cessation
- 2004-12-27 EP EP19196238.0A patent/EP3643702A1/en not_active Withdrawn
- 2004-12-27 CN CNB2004800398051A patent/CN100469765C/en active Active
- 2004-12-27 ES ES15194684T patent/ES2767136T3/en active Active
- 2004-12-27 MX MXPA06007678A patent/MXPA06007678A/en active IP Right Grant
- 2004-12-27 HU HUE04804405A patent/HUE027357T2/en unknown
- 2004-12-27 PL PL04804405T patent/PL1704141T3/en unknown
- 2004-12-27 CA CA2551409A patent/CA2551409C/en active Active
- 2004-12-27 DK DK04804405.1T patent/DK1704141T3/en active
- 2004-12-27 AP AP2006003638A patent/AP2006003638A0/en unknown
- 2004-12-27 SI SI200432309T patent/SI1704141T1/en unknown
- 2004-12-27 KR KR1020087000325A patent/KR100854838B1/en active IP Right Grant
- 2004-12-27 EP EP15194684.5A patent/EP3002277B1/en active Active
- 2004-12-27 KR KR1020067013440A patent/KR100850133B1/en active IP Right Grant
- 2004-12-27 ME MEP-2016-79A patent/ME02433B/en unknown
- 2004-12-27 NZ NZ548271A patent/NZ548271A/en unknown
- 2004-12-27 UA UAA200607454A patent/UA84726C2/en unknown
- 2004-12-31 TW TW093141786A patent/TWI337994B/en active
-
2005
- 2005-01-03 AR ARP050100012A patent/AR047081A1/en active IP Right Grant
- 2005-01-03 MY MYPI20050009A patent/MY147181A/en unknown
- 2005-01-04 UY UY28709A patent/UY28709A1/en not_active Application Discontinuation
- 2005-01-04 PA PA20058620901A patent/PA8620901A1/en unknown
- 2005-01-04 PE PE2005000037A patent/PE20051052A1/en active IP Right Grant
- 2005-01-05 US US11/029,698 patent/US7273946B2/en active Active
- 2005-10-18 GT GT200500293A patent/GT200500293A/en unknown
-
2006
- 2006-06-19 IL IL176416A patent/IL176416A/en active IP Right Grant
- 2006-06-28 ZA ZA200605354A patent/ZA200605354B/en unknown
- 2006-06-29 EC EC2006006684A patent/ECSP066684A/en unknown
- 2006-06-30 CR CR8498A patent/CR8498A/en unknown
- 2006-07-04 TN TNP2006000210A patent/TNSN06210A1/en unknown
- 2006-07-05 MA MA29169A patent/MA28284A1/en unknown
- 2006-08-07 NO NO20063567A patent/NO337217B1/en unknown
-
2007
- 2007-03-30 HK HK07103447.6A patent/HK1096084A1/en unknown
- 2007-08-20 US US11/841,628 patent/US7449469B2/en active Active
-
2008
- 2008-09-15 US US12/210,975 patent/US7629345B2/en active Active
-
2009
- 2009-11-06 US US12/613,985 patent/US7910767B2/en active Active
-
2011
- 2011-02-11 US US13/025,740 patent/US8058467B2/en active Active
- 2011-03-11 CR CR20110131A patent/CR20110131A/en unknown
-
2014
- 2014-12-22 AR ARP140104875A patent/AR098931A2/en not_active Application Discontinuation
-
2015
- 2015-10-08 NO NO20151341A patent/NO339685B1/en unknown
-
2016
- 2016-04-26 CY CY20161100340T patent/CY1117417T1/en unknown
- 2016-05-11 HR HRP20160500TT patent/HRP20160500T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20051052A1 (en) | NITROOXY DERIVATIVES OF PROSTAGLANDINS | |
| AU2006227757B2 (en) | Enhanced bimatoprost ophthalmic solution | |
| TWI350170B (en) | Treating agent for glaucoma comprising rho kinase inhibitor and prostaglandin | |
| PE20070120A1 (en) | DERIVATIVES OF PROSTAGLANDIN | |
| RU2010142353A (en) | WATER PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOLIC COMPLEXES | |
| PE20091065A1 (en) | BIS- (SULFONYLAMINE) DERIVATIVES IN THERAPY 066 | |
| JP6449205B2 (en) | Pharmaceutical composition containing pyridylaminoacetic acid compound and polyoxyethylene castor oil | |
| ES2458493T8 (en) | Topical ophthalmic composition of fluprostenol for the treatment of glaucoma and ocular hypertension | |
| PE20011371A1 (en) | DERIVATIVES OF 3- (3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-IL) -EXO-8-AZABICYCLO [3.2.1] OCTANE AS ANTAGONISTS OF CCR5 CHEMOKIN RECEPTORS | |
| CA2570148A1 (en) | Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide | |
| JP2008528490A (en) | Stable prostaglandin-containing composition | |
| RU2014103544A (en) | COMBINATION OF FIXED DOSES OF BIMATOPROST AND BRIMONIDINE | |
| WO2009129187A3 (en) | Combination therapy for glaucoma | |
| RU2013107744A (en) | BIMATOPROST AND THYMOLOL SOLUTIONS NOT CONTAINING CONSERVANTS | |
| CN101400354A (en) | Aqueous composition | |
| DK1395263T3 (en) | 3, 7 or 3 and 7 thia or oxaprostanoic acid derivatives as agents for lowering intraocular pressure | |
| RU2004111357A (en) | COMBINED AGENTS FOR TREATMENT OF GLAUCOMA | |
| JP2005263792A (en) | Clear latanoprost eye lotion | |
| ES2452026T3 (en) | Prostaglandins and analogs as agents to lower intraocular pressure | |
| RU2009120545A (en) | PAI-1 BINDING MODULATORS FOR TREATMENT OF EYE DISEASES | |
| JP2006089460A (en) | Ophthalmic thickening agent | |
| US10047047B2 (en) | Nitric oxide donating derivatives of latanoprost free acid | |
| RU2013147049A (en) | S1P ANTAGONISTS AS AUXILIARY MEANS FOR REDUCING IN-ORGAL PRESSURE | |
| RU2008143219A (en) | Prenyltransferase inhibitors for the control of ocular hypertension and treatment of glaucoma | |
| JP2008009145A (en) | Contact lens cleaning composition, and contact lens cleaning method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal | ||
| FG | Grant, registration |